Gustavo Pacheco-Rodriguez Selected Research

lipoarabinomannan (LAM)

1/2022	Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene.
1/2022	ETV2 regulates PARP-1 binding protein to induce ER stress-mediated death in tuberin-deficient cells.
10/2021	The lung microbiome in end-stage Lymphangioleiomyomatosis.
1/2018	CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis.
1/2018	The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.
1/2018	Effect of beta-agonists on LAM progression and treatment.
3/2015	Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.
1/2014	Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis.
9/2013	Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.
9/2013	Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gustavo Pacheco-Rodriguez Research Topics

Disease

27	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2022 - 03/2002
19	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 03/2002
17	Neoplasms (Cancer) 01/2021 - 09/2005
8	Angiomyolipoma 01/2018 - 12/2004
7	Lung Diseases (Lung Disease) 01/2022 - 12/2004
5	Disease Progression 01/2019 - 07/2010
5	Lymphangiomyoma 03/2015 - 12/2009
4	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2007
4	Pleural Effusion (Pleural Effusions) 01/2018 - 11/2007
3	Cysts 03/2010 - 07/2006
2	Respiratory Insufficiency (Respiratory Failure) 10/2021 - 03/2002
2	Carcinogenesis 01/2017 - 09/2005
2	Leiomyoma (Uterine Fibroids) 09/2013 - 03/2010
2	Pneumothorax 08/2010 - 03/2010
2	Hamartoma 03/2010 - 03/2008
2	Melanoma (Melanoma, Malignant) 01/2010 - 02/2009
2	Fibroma (Fibromatosis) 03/2008 - 09/2005
2	Angiofibroma 03/2008 - 09/2005
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2021
1	Rare Diseases (Rare Disease) 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Idiopathic Pulmonary Fibrosis 07/2014
1	Adenocarcinoma of Lung 09/2013
1	Hypoxia (Hypoxemia) 01/2011
1	Dyspnea (Shortness of Breath) 03/2010
1	Chylothorax 03/2010
1	Hemorrhage 03/2010
1	Lymphadenopathy 12/2009
1	Breast Neoplasms (Breast Cancer) 02/2009
1	Chylous Ascites 11/2007
1	Fibrosis (Cirrhosis) 09/2005
1	Adenocarcinoma 09/2005
1	Lymphatic Abnormalities 12/2004

Drug/Important Bio-Agent (IBA)

22	lipoarabinomannan (LAM)IBA 01/2022 - 03/2002
16	trans-sodium crocetinate (crocetin)IBA 01/2021 - 12/2004
6	Sirolimus (Rapamycin)FDA Link 01/2021 - 09/2005
4	Vascular Endothelial Growth Factor DIBA 01/2021 - 12/2009
3	Tuberous Sclerosis Complex 2 ProteinIBA 01/2011 - 09/2005
3	Messenger RNA (mRNA)IBA 08/2010 - 09/2005
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 08/2010
2	ChemokinesIBA 01/2010 - 02/2009
2	TOR Serine-Threonine KinasesIBA 03/2008 - 07/2006
2	Tuberous Sclerosis Complex 1 ProteinIBA 11/2007 - 09/2005
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Methacholine Chloride (Methacholine)FDA Link 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	ReninIBA 01/2019
1	AngiotensinsIBA 01/2019
1	AntigensIBA 01/2018
1	Bronchodilator Agents (Bronchodilators)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Syk KinaseIBA 01/2017
1	Melanoma-Specific AntigensIBA 03/2015
1	Hormones (Hormone)IBA 09/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013
1	OsteoprotegerinIBA 09/2013
1	MitogensIBA 01/2011
1	Erythropoietin FDA Link 01/2011
1	ProlactinIBA 08/2010
1	Prolactin Receptors (Prolactin Receptor)IBA 08/2010
1	Estrogens (Estrogen)FDA Link 07/2010
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2010
1	Chemokine ReceptorsIBA 01/2010
1	EpiregulinIBA 03/2008
1	Hyaluronic Acid (Hyaluronan)IBA 11/2007
1	Conditioned Culture MediaIBA 09/2005
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2005
1	LY 303511IBA 09/2005

Therapy/Procedure

2	Therapeutics 01/2018 - 07/2010
2	Lung Transplantation 04/2015 - 12/2004